Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heyan Kuntai capsule combined with hormone replacement therapy for premature ovarian insufficiency
ChiCTR1800017774Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Aug 2018
- Countries
- 1
01
Overview
Phase 4, open-label trial of estradiol and Kuntai in ovarian hypofunction (POI) (3 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoints: Basal serum sex hormones and Kupperman Index. Planned start Aug 2018; status: not yet recruiting.
02
Drugs
estradiolKuntai
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on ChiCTR1800017774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017774.